Precision Medicine in Pancreatic Ductal Adenocarcinoma: The Impact of Targeted Therapies on Survival of Patients Harboring Actionable Mutations

Background: Pancreatic ductal adenocarcinoma (PDAC) is the third leading cause of death by cancer worldwide. Mostly diagnosed with locally advanced or metastatic disease, patients lack treatment options. Gene alterations (GAs) are frequently observed in PDAC, some of which are considered for molecul...

وصف كامل

التفاصيل البيبلوغرافية

المؤلفون الرئيسيون:	Anthony Tarabay, Alice Boileve, Cristina Smolenschi, Leony Antoun, Marine Valery, Alina Fuerea, Audrey Perret, Pascal Burtin, Simona Cosconea, Hichem Belkhodja, David Malka, Valérie Boige, Antoine Hollebecque, Michel Ducreux
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	MDPI AG 2023-09-01
سلاسل:	Biomedicines
الموضوعات:	PDAC precision medicine gene alterations molecular profiling molecular targeted therapies
الوصول للمادة أونلاين:	https://www.mdpi.com/2227-9059/11/9/2569
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!